Sol-Gel Technologies Ltd. (SLGL) stock
SLGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026Score 10/30
$53.36+0.53 (+1.00%)
Close on Nov 18, 2026Market cap $148.67MP/E –Yield –
Sol-Gel Technologies revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $19.39M, up 68.0% from the year before. The highest annual figure on record is $31.27M in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.39M | +68.0% |
| FY2024 | Dec 31, 2024 | $11.54M | +642.5% |
| FY2023 | Dec 31, 2023 | $1.55M | -60.0% |
| FY2022 | Dec 31, 2022 | $3.88M | -87.6% |
| FY2021 | Dec 31, 2021 | $31.27M | +256.5% |
| FY2020 | Dec 31, 2020 | $8.77M | -61.7% |
| FY2019 | Dec 31, 2019 | $22.90M | +17655.0% |
| FY2018 | Dec 31, 2018 | $129.00K | -25.9% |
| FY2017 | Dec 31, 2017 | $174.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $591.00K | -83.2% |
| Q2 FY2025 | Jun 30, 2025 | $17.26M | +1760.0% |
| Q2 FY2024 | Jun 30, 2024 | $5.43M | +379.5% |
| Q2 FY2023 | Jun 30, 2023 | $594.00K | -92.4% |
| Q2 FY2022 | Jun 30, 2022 | $3.52M | +7079.6% |
| Q2 FY2021 | Jun 30, 2021 | $928.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $1.13M | – |
| Q2 FY2019 | Jun 30, 2019 | $7.79M | – |
| Q2 FY2018 | Jun 30, 2018 | $49.00K | – |
See a number that looks wrong?